B-cell prolymphocytic leukemia historical perspective: Difference between revisions
Carlos Lopez (talk | contribs) No edit summary |
Carlos Lopez (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}};{{CLG}} | {{CMG}};{{CLG}} | ||
== Overview == | == Overview == | ||
B-cell prolymphocytic leukemia was first described in 1974 by Galton | B-cell prolymphocytic leukemia was first described in 1974 by Galton David Abraham Goitein. | ||
==B-cell prolymphocytic leukemia== | ==B-cell prolymphocytic leukemia== | ||
B-cell prolymphocytic leukemia initially, when first described by Galton et al. in 1974 was considered a variant of | B-cell prolymphocytic leukemia initially, when first described by Galton et al. in 1974 was considered a variant of chronic lymphoid leukemia.<ref name=TPLL>{{cite web | title = National Cancer Institute| url = https://www.google.com/search?q=B-cell+prolymphocytic+leukemia+was+first+described+in+1974+by+Galton+et+al.&ie=utf-8&oe=utf-8 | ||
}}</ref> | }}</ref> | ||
Revision as of 00:43, 23 October 2015
|
B-cell prolymphocytic leukemia |
|
Differentiating B-cell prolymphocytic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
B-cell prolymphocytic leukemia historical perspective On the Web |
|
American Roentgen Ray Society Images of B-cell prolymphocytic leukemia historical perspective |
|
FDA on B-cell prolymphocytic leukemia historical perspective |
|
CDC on B-cell prolymphocytic leukemia historical perspective |
|
B-cell prolymphocytic leukemia historical perspective in the news |
|
Blogs on B-cell prolymphocytic leukemia historical perspective |
|
Directions to Hospitals Treating B-cell prolymphocytic leukemia |
|
Risk calculators and risk factors for B-cell prolymphocytic leukemia historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Carlos A Lopez, M.D. [2]
Overview
B-cell prolymphocytic leukemia was first described in 1974 by Galton David Abraham Goitein.
B-cell prolymphocytic leukemia
B-cell prolymphocytic leukemia initially, when first described by Galton et al. in 1974 was considered a variant of chronic lymphoid leukemia.[1]